Long-read sequencing, also known as third-generation sequencing, is a class of DNA sequencing method. Long-read technologies are helping to overcome the early limitations in accuracy, throughput, and broadening their application in genomics.
Global Long-read Sequencing Market: Overview
- Long-read sequencing, also known as third-generation sequencing, is a class of DNA sequencing method. Long-read technologies are helping to overcome the early limitations in accuracy, throughput, and broadening their application in genomics.
- Long-read sequencing offers a number of advantages over short-read sequencing. Short-read sequencers such as Illumina’s NovaSeq, HiSeq produce read up to 600 bases of DNA, while long-read sequencing technologies can generate read more than 10,000 bases. Moreover, long-reads can improve genome assembly, mapping certainty, transcript isoform identification, and detection of structural variants of DNA.
- Wider use of such long-read sequencing technologies in the clinical context may rapidly improve the understanding of cancer, pathogen evolution, drug resistance, and genetic diversity in complex regions of the genome that have important implications for clinical care
Read Report Overview - https://www.transparencymarketresearch.com/longread-sequencing-market.html
Key Drivers and Restraint of Global Long-read Sequencing Market
- Long-read sequencing technologies are rapidly moving toward the support of high resolution histocompatibility leucocyte antigen (HLA) typing for transplant registries in certain regions as high resolution typing potentially provides better matching of organs and clinical outcomes of patients undergoing transplantation show good results.
- Using long-range PCR amplicons with barcoding and long-read technology also allows better description of genes from pseudogenes, such as for sequencing PKD1 for diagnosing autosomal-dominant polycystic kidney disease, for which diagnostic accuracy of NGS technologies has been limited and this drives the demand for long-read sequencing.
- However, higher cost per base relative to short read sequencing is one of the factors that are restraining the market
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77289
North America to Account for Major Share of Global Long-read Sequencing Market
- In terms of region, the global long-read sequencing market can be segmented into North America, Europe, Asia Pacific, and Rest of World. North America is expected to dominate the global market during the forecast period.
- North America is projected to account for a significant share of the global market due to availability of well-defined reimbursement policies from public and private health insurance firms which help provide the patients easy access of diagnosis and extensive research & development activities.
- Asia Pacific is expected to contribute to a substantial share of the market in terms of revenue during the forecast period due to the emergence of the region as a major manufacturing hub and rising expertise and academic excellence in the region.
Pre Book Long-read Sequencing Market Report at - https://www.transparencymarketresearch.com/checkout.php?rep_id=77289<ype=S
Key Players Operating in Global Long-read Sequencing Market
Major players operating in the global long-read sequencing market include:
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies
- Quantapore, Inc.
- Stratos Genomics.
- MicrobesNG
- FG Technologies
- Genexa AG
More Trending Reports by Transparency Market Research:
Safety Glasses Market: Safety eyewear products are available in various sizes and types. Moreover, choosing suitable safety eyewear products depends on multiple parameters such as size, safety, blocker type, comfort, and budget.
Dyslipidemia Therapeutics Market: Dyslipidemia, a key risk factor for cardiovascular disease (CVD), poses high health burden to the developed world, thus, propelling the need for effective therapies that are well tolerated. The condition is characterized by low-density lipoprotein-cholesterol (LDL-C) and triglyceride concentrations. Statins have long been preferred in dyslipidemia therapeutics market for dramatically reducing LDL-C levels, and hence the CVD risks.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/